Skip to main content

Bone/OP&OA

Podcast microphone headphones
Day 1 (part one): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 1 (part two): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 3: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 2 (part two) ACR 2019 Podcast
RheumNow
RT @_connectedcare: Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessationAnecdotally, there are people who…

Dr Irwin Lim _connectedcare

8 months 3 weeks ago

Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655

#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention1366 Self Joint exams1120 Rheum burnout1310 OA Hx565 Enteropathic arthritis Re

Dr. John Cush RheumNow

8 months 3 weeks ago

#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

RT @EBRheum: #ACR19 Guidelines for OA: my take home is this truly astonishing funnel plotVirtually zero small negative studies and dozens…

Mike Putman EBRheum

8 months 3 weeks ago

#ACR19 Guidelines for OA: my take home is this truly astonishing funnel plot Virtually zero small negative studies and dozens of small positive studies Clear trend toward NO effect w/more precision in trial Publication bias et al. in action!! @RheumNow https://t.co/65nKzghobz

Methotrexate and Prednisone for Hand OA: Dr. Paul Sufka

Dr. Sufka discusses abstracts #1759 and #1760 at the 2019 ACR/ARP annual meeting in Atlanta. 

Bad to the Bone: Dr. Chad Deal

Dr. Deal highlights the session 'Bad to the Bone: Metabolic Bone Disease" at the 2019 ACR/ARP Annual Meeting in Atlanta. 

RT @KDAO2011: Do you still look at synovial fluid under the microscope? @rheumnow #acr19

k dao KDAO2011

8 months 3 weeks ago

Do you still look at synovial fluid under the microscope? @rheumnow #acr19

RT @psufka: #ACR19 poll: Do you use Prednisone to manage symptoms of hand osteoarthritis? @RheumNow

Dr. Paul Sufka psufka

8 months 3 weeks ago

#ACR19 poll: Do you use Prednisone to manage symptoms of hand osteoarthritis? @RheumNow

RT @drdavidliew: @RheumNow What is your primary pharmacotherapy for inflammatory-type erosive hand OA?#ACR19 @RheumNow Plenary II ABST175…

David Liew drdavidliew

8 months 4 weeks ago

@RheumNow What is your primary pharmacotherapy for inflammatory-type erosive hand OA? #ACR19 @RheumNow Plenary II ABST1759/1760

The Great Debate: Dr. Chad Deal

Dr. Deal highlights The Great Debate: Anabolic Agents Are/Are Not Appropriate First-Line Therapy for Glucocorticoid-Induced Osteoporosis, and offers his opinion on this debate at the 2019 ACR/ARP Annual Meeting in Atlanta. 

RT @uptoTate: OP related fracture risk projected to increase to 33% by 2030. Medicare cohort from 2010- 2014 data review suggestions worsen…

Dr. Rachel Tate uptoTate

8 months 4 weeks ago

OP related fracture risk projected to increase to 33% by 2030. Medicare cohort from 2010- 2014 data review suggestions worsening fracture management. https://t.co/anG80uMjEV abs#1872 #ACR19 @RheumNow

RT @KDAO2011: #acr19 @rheumnow Great debate Who won? Dr Saag (62% yes votes)But Dr Humphrey NO-anabolic stance as first line for GIO ma…

k dao KDAO2011

8 months 4 weeks ago

#acr19 @rheumnow Great debate Who won? Dr Saag (62% yes votes) But Dr Humphrey NO-anabolic stance as first line for GIO make sense for many patients; antiresorptives do work for GIO and cost per fracture prevented is so much less

RT @DrPetryna: #ACR19 @rheumnow abs1759 1-y prospective, monocentric, DB, PBO-cont stdy MTX (10mg/wk) vs PBO in erosive hand OA demonstrate…

Olga Petryna DrPetryna

8 months 4 weeks ago

#ACR19 @rheumnow abs1759 1-y prospective, monocentric, DB, PBO-cont stdy MTX (10mg/wk) vs PBO in erosive hand OA demonstrates no improvement in VAS pain score with MTX. at the same time MTX significantly ⬇️progression of joint damage vs PBO & seems to facilitate bone remodeling

RT @drdavidliew: @RheumNow What about pred for hand OA? Well PNL 10 has an effect while you're taking it, with reduction of synovial thicke…

David Liew drdavidliew

8 months 4 weeks ago

@RheumNow What about pred for hand OA? Well PNL 10 has an effect while you're taking it, with reduction of synovial thickening, and in this study was well tolerated. Stop taking it, and you're back to baseline. Leiden #ACR19 ABST 1760 @RheumNow https://t.co/aw4UNHol7J

RA pts have a high prevalence of osteoporosis (OP-34%) & vertebral osteoporotic Fx (VOPF-20%). OP risk with Older age, female sex, lower BMI, high

Dr. John Cush RheumNow

9 months ago

RA pts have a high prevalence of osteoporosis (OP-34%) & vertebral osteoporotic Fx (VOPF-20%). OP risk with Older age, female sex, lower BMI, higher Dz activity & severity. VOPF risk driven by older age & higher GC daily dose. https://t.co/BbSmUHPrHf

×